Global SmallMolecule API Market, by API Type (Artificial, and Natural), by Category(Analgesic, Anesthetics, Anticonvulsants, Antimetabolites, Antibacterial,Alkylating Agents, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 126.6 billionin 2017, and is projected to exhibit a CAGR of 9.1% over the forecast period(2018 – 2026).
Strong research and developmentin API by market players to augment the market growth Key players in the marketare focused on research and development in order to develop novel products toaddress the critical and unmet needs of patients. For instance, according toIndia Brand Equity Foundation (IBEF), investment in research and development byIndia-based pharmaceutical companies increased (in term of sales) from 5.3% to8.5% from 2012 to 2018. Similarly, as per U.S. Food and Drug Administration(FDA), in March 2016, there were around 37 drugs in clinical development fortreating serious bacterial infections. These drugs are intended to be primarilylaunched in the U.S. Moreover, increasing prevalence of various types ofcancers worldwide is expected to boost the market growth. International Agencyfor Research on Cancer published the GLOBOCAN 2018 report, which focuses ongeographic variability of cancer incidence and mortality rate across 20 worldregions. The report projected 18.1 million new cancer cases (17.0 millionexcluding non-melanoma skin cancer) and 9.6 million cancer deaths (9.5 millionexcluding non-melanoma skin cancer) in 2018.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2423
Browse 34 Market Data Tables and23 Figures spread through 261 Pages and in-depth TOC on ‘Small Molecule APIMarket’- Global Forecast to 2026, by API Type (Artificial, and Natural), byCategory (Analgesic, Anesthetics, Anticonvulsants, Antimetabolites,Antibacterial, Alkylating Agents, and Others), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa)
Key players in the market arefocused on adopting strategies such as mergers and acquisitions to enhancetheir product portfolio. In October 2017, CordenPharma announced acquisition ofPfizer Inc., a manufacturing facility of API Hospira in Colorado, U.S. Thisacquisition strengthened the CordenParma’s position, as a leading ContractDevelopment & Manufacturing Organization (CDMO).
Key Takeaways of the SmallMolecule API Market:
The global small molecule APImarket is expected to exhibit a CAGR of 9.1% over the forecast period, owing toincreasing prevalence of cancer and other diseases, extensive research anddevelopment for API production and expansion strategies by the market players.In October 2016, Cambrex Corporation acquired the 35,000-square-foot High Pointsite, formerly owned by PharmaCore
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/small-molecule-api-market-2423
Among API type, the artificialsegment held a dominant position in the small molecule API market in 2018,owing to high prevalence of chronic pain diseases worldwide
Among Category, the analgesicsegment hold a dominant position in the small molecule API market in 2018, asthe majority of recent generics launches are in form of sublingual films usedin treatment of opioid dependence.
Key players operating in theglobal small molecule API market include, Siegfried, Sanofi, Johnson Matthey,Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs,Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and FaranShimi Pharmaceutical Co.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2423
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
